Cargando…

Model-Based Prediction of Acid Suppression and Proposal of a New Dosing Regimen of Fexuprazan in Humans

Fexuprazan is a potassium-competitive acid blocker (P-CAB). The compounds in this newly developed drug family suppress intragastric acidity. As there are already other acid-suppressing drugs on the market, such as H(2) antagonists and proton pump inhibitors (PPIs), it would be informative to compare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Min-Soo, Lee, Nora, Lee, Areum, Chae, Yoon-Jee, Chung, Suk-Jae, Lee, Kyeong-Ryoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230547/ https://www.ncbi.nlm.nih.gov/pubmed/35745628 http://dx.doi.org/10.3390/ph15060709

Ejemplares similares

Development of Physiologically Based Pharmacokinetic Model for Orally Administered Fexuprazan in Humans
por: Jeong, Yoo-Seong, et al.
Publicado: (2021)

Efficacy and Safety of Fexuprazan in Patients with Acute or Chronic Gastritis
por: Kim, Gwang Ha, et al.
Publicado: (2023)

Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis
por: Lee, Kang Nyeong, et al.
Publicado: (2022)

Pharmacokinetic Estimation Models-based Approach to Predict Clinical Implications for CYP Induction by Calcitriol in Human Cryopreserved Hepatocytes and HepaRG Cells
por: Chae, Yoon-Jee, et al.
Publicado: (2021)

Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy Subjects
por: Oh, JungJin, et al.
Publicado: (2023)

Size-reduced fexuprazan 20 mg demonstrated the optimal bioavailability and bioequivalence with the reference formulation
por: Yang, A-Young, et al.
Publicado: (2023)

A Comparative Pharmacokinetic Study of Fexuprazan 10 mg: Demonstrating Bioequivalence with the Reference Formulation and Evaluating Steady State
por: Shin, Wonsuk, et al.
Publicado: (2023)

Findings on In Vitro Transporter-Mediated Drug Interactions and Their Follow-Up Actions for Labeling: Analysis of Drugs Approved by US FDA between 2017 and 2021
por: Lee, Kyeong-Ryoon, et al.
Publicado: (2022)

Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans
por: Kim, Min-Soo, et al.
Publicado: (2023)

Bioanalysis of niclosamide in plasma using liquid chromatography-tandem mass and application to pharmacokinetics in rats and dogs
por: Choi, Hae-In, et al.
Publicado: (2021)

A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis
por: Jung, Jin Ah, et al.
Publicado: (2015)

Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients
por: Kawasuji, Hitoshi, et al.
Publicado: (2021)

A retrospective analysis of the follicle-stimulating hormone starting dose in expected normal responders undergoing their first in vitro fertilization cycle: proposed dose versus empiric dose
por: Lee, Dayong, et al.
Publicado: (2018)

Quercetin Is a Flavonoid Breast Cancer Resistance Protein Inhibitor with an Impact on the Oral Pharmacokinetics of Sulfasalazine in Rats
por: Song, Yoo-Kyung, et al.
Publicado: (2020)

Pharmacokinetic Characterization of Supinoxin and Its Physiologically Based Pharmacokinetic Modeling in Rats
por: Song, Yoo-Kyung, et al.
Publicado: (2021)

A Novel Propofol Dosing Regimen for Pediatric Sedation during Radiologic Tests
por: Min, Ji-Young, et al.
Publicado: (2022)

Continuous-Infusion Vancomycin in Neonates: Assessment of a Dosing Regimen and Therapeutic Proposal
por: Tauzin, Manon, et al.
Publicado: (2019)

Population Pharmacokinetic Method to Predict Within-Subject Variability Using Single-Period Clinical Data
por: Kang, Won-ho, et al.
Publicado: (2021)

A Case of Sterile Abscess Induced by Hyaluronic Acid Filler Injection
por: Shin, Jee Yon, et al.
Publicado: (2019)

Rifabutin-based High-dose Proton-pump Inhibitor and Amoxicillin Triple Regimen as the Rescue treatment for Helicobacter pylori
por: Lim, Hyun Chul, et al.
Publicado: (2014)

A population PK–PD model of YH4808, a novel P‐CAB, and intragastric pH that incorporated negative feedback by increased intragastric pH onto the systemic exposure to YH4808
por: Chung, Tae Kyu, et al.
Publicado: (2022)

Busulfan plus melphalan versus high-dose melphalan as conditioning regimens in autologous stem cell transplantation for newly diagnosed multiple myeloma
por: Byun, Ja Min, et al.
Publicado: (2018)

A New Helicase Assay Based on Graphene Oxide for Anti-Viral Drug Development
por: Jang, Hongje, et al.
Publicado: (2013)

Severe Pulmonary Adverse Effects in Lymphoma Patients Treated with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) Regimen Plus Rituximab
por: Lim, Kyu-Hyoung, et al.
Publicado: (2010)

Pretreatment serum human chorionic gonadotropin cutoff value for medical treatment success with single-dose and multi-dose regimen of methotrexate in tubal ectopic pregnancy
por: Kim, Junhwan, et al.
Publicado: (2017)

A Proposal for Early Dosing Regimens in Heart Transplant Patients Receiving Thymoglobulin and Calcineurin Inhibition
por: Barten, Markus J., et al.
Publicado: (2016)

739. Prediction of Cefiderocol Pharmacokinetics and Probability of Target Attainment in Pediatric Subjects for Proposing Dose Regimens
por: Katsube, Takayuki, et al.
Publicado: (2019)

Determination of a radotinib dosage regimen based on dose–response relationships for the treatment of newly diagnosed patients with chronic myeloid leukemia
por: Noh, Hayeon, et al.
Publicado: (2018)

Comparison of Different Gum-Based Thickeners Using a Viscometer and Line Spread Test: A Preliminary Study
por: Park, Jae Hyeon, et al.
Publicado: (2014)

Randomized clinical trial comparing fixed-time split dosing and split dosing of oral Picosulfate regimen for bowel preparation
por: Jun, Jae Hyuck, et al.
Publicado: (2017)

Epstein-Barr Virus miR-BART17-5p Promotes Migration and Anchorage-Independent Growth by Targeting Kruppel-Like Factor 2 in Gastric Cancer
por: Yoon, Jae Hee, et al.
Publicado: (2020)

Prospective Randomization Trial of G-CSF-Primed Induction Regimen versus Standard Regimen in Patients with AML
por: Lee, Yoo Jin, et al.
Publicado: (2011)

Characteristics of Adverse Effects When Using High Dose Short Term Steroid Regimen
por: Min, Kyung Hyun, et al.
Publicado: (2012)

Redefining Chronic Inflammation in Aging and Age-Related Diseases: Proposal of the Senoinflammation Concept
por: Chung, Hae Young, et al.
Publicado: (2019)

Pharmacokinetics of Levornidazole Tablet in Healthy Chinese Subjects and Proposed Dosing Regimen Based on Pharmacokinetic/Pharmacodynamic Analysis
por: Wu, Hailan, et al.
Publicado: (2021)

Adherence to triple‐component antihypertensive regimens is higher with single‐pill than equivalent two‐pill regimens: A randomized controlled trial
por: Sung, Jidong, et al.
Publicado: (2021)

Treatment Outcome of Adult Acute Lymphocytic Leukemia with VPD(L) Regimen: analysis of Prognostic Factors
por: Park, Sook-Ryun, et al.
Publicado: (2003)

A target-controlled infusion regimen for reducing remifentanil-induced coughs
por: Kim, Jong-Yeop, et al.
Publicado: (2012)

Safety and Efficacy of Low-Volume Preparation in the Elderly: Oral Sulfate Solution on the Day before and Split-Dose Regimens (SEE SAFE) Study
por: Kwak, Min Seob, et al.
Publicado: (2019)

Cancer Treatment Dosing Regimens of Zoledronic Acid Result in Near-Complete Suppression of Mandible Intracortical Bone Remodeling in Beagle Dogs
por: Allen, Matthew R, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_pu4boohpl154otbgpo0vltdomp